Stonehage Fleming Financial Services’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,775
| Closed | -$132K | – | 248 |
|
|
2024
Q1 | $132K | Buy |
+1,775
| New | +$136K | 0.01% | 107 |
|
|
2023
Q4 | – | Sell |
-1,775
| Closed | -$124K | – | 245 |
|
|
2023
Q3 | $124K | Hold |
1,775
| – | – | 0.01% | 165 |
|
|
2023
Q2 | $123K | Hold |
1,775
| – | – | ﹤0.01% | 142 |
|
|
2023
Q1 | $132K | Buy |
+1,775
| New | +$149K | 0.01% | 107 |
|
|
2022
Q4 | – | Sell |
-13,962
| Closed | -$1.33M | – | 178 |
|
|
2022
Q3 | $1.33M | Hold |
13,962
| – | – | 0.1% | 29 |
|
|
2022
Q2 | $1.29M | Hold |
13,962
| – | – | 0.05% | 54 |
|
|
2022
Q1 | $1.41M | Hold |
13,962
| – | – | 0.04% | 59 |
|
|
2021
Q4 | $1.44M | Hold |
13,962
| – | – | 0.04% | 61 |
|
|
2021
Q3 | $1.19M | Hold |
13,962
| – | – | 0.03% | 68 |
|
|
2021
Q2 | $1.17M | Hold |
13,962
| – | – | 0.03% | 70 |
|
|
2021
Q1 | $1.05M | Hold |
13,962
| – | – | 0.04% | 76 |
|
|
2020
Q4 | $954K | Hold |
13,962
| – | – | 0.03% | 80 |
|
|
2020
Q3 | $815K | Buy |
+13,962
| New | +$869K | 0.03% | 75 |
|
|
2020
Q2 | – | Sell |
-13,962
| Closed | -$828K | – | 157 |
|
|
2020
Q1 | $828K | Hold |
13,962
| – | – | 0.04% | 63 |
|
|
2019
Q4 | $1.04M | Hold |
13,962
| – | – | 0.05% | 62 |
|
|
2019
Q3 | $881K | Buy |
+13,962
| New | +$827K | 0.04% | 71 |
|
|
2019
Q1 | – | Sell |
-4,600
| Closed | -$301K | – | 194 |
|
|
2018
Q4 | $301K | Buy |
+4,600
| New | +$343K | 0.02% | 137 |
|
|
2018
Q1 | – | Sell |
-34,700
| Closed | -$2.52M | – | 222 |
|
|
2017
Q4 | $2.52M | Sell |
34,700
-16,725
| -33% | -$1.22M | 0.14% | 45 |
|
|
2017
Q3 | $4.18M | Sell |
51,425
-20,388
| -28% | -$1.61M | 0.2% | 41 |
|
|
2017
Q2 | $5.78M | Sell |
71,813
-29,876
| -29% | -$2.36M | 0.35% | 35 |
|
|
2017
Q1 | $7.98M | Buy |
101,689
+9,942
| +11% | +$794K | 0.51% | 34 |
|
|
2016
Q4 | $7.24M | Sell |
91,747
-2,645
| -3% | -$214K | 0.45% | 34 |
|
|
2016
Q3 | $8.4M | Buy |
94,392
+14,544
| +18% | +$1.37M | 0.5% | 36 |
|
|
2016
Q2 | $7.64M | Buy |
79,848
+27,263
| +52% | +$2.72M | 0.5% | 34 |
|
|
2016
Q1 | $5.46M | Buy |
52,585
+41,585
| +378% | +$4.04M | 0.36% | 34 |
|
|
2015
Q4 | $1.07M | Sell |
11,000
-664
| -6% | -$65K | 0.09% | 49 |
|
|
2015
Q3 | $1.13M | Hold |
11,664
| – | – | 0.12% | 49 |
|
|
2015
Q2 | $1.22M | Hold |
11,664
| – | – | 0.15% | 45 |
|
|
2015
Q1 | $1.2M | Hold |
11,664
| – | – | 0.14% | 50 |
|
|
2014
Q4 | $1.12M | Buy |
+11,664
| New | +$1.03M | 0.13% | 49 |
|
Other funds holding CVS
Stonehage Fleming Financial Services's CVS Position: Q2 2024 in Review
Stonehage Fleming Financial Services sold out of CVS Health (CVS) in Q2 2024, closing a stake of 1,775 shares — an estimated $132K sold.
Stonehage Fleming Financial Services first reported a position in CVS in Q4 2014 and held it in 30 quarters. The position peaked at $8.4M in Q3 2016. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Stonehage Fleming Financial Services reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Stonehage Fleming Financial Services sold 1,775 CVS Health shares in Q2 2024, an estimated $132K.
- Stonehage Fleming Financial Services first reported a position in CVS Health in Q4 2014 and held it in 30 quarters.
- Stonehage Fleming Financial Services's CVS Health position peaked at $8.4M in Q3 2016.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Stonehage Fleming Financial Services's 13F filing for Q2 2024, filed 5 Aug 2024.